Joseph M Miller - Net Worth and Insider Trading
Joseph M Miller Net Worth
The estimated net worth of Joseph M Miller is at least $4 Million dollars as of 2024-11-29. Joseph M Miller is the CFO of Aurinia Pharmaceuticals Inc and owns about 495,928 shares of Aurinia Pharmaceuticals Inc (AUPH) stock worth over $4 Million. Joseph M Miller is also the CFO of Avalo Therapeutics Inc and owns about 17 shares of Avalo Therapeutics Inc (AVTX) stock worth over $162. Details can be seen in Joseph M Miller's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph M Miller has not made any transactions after 2024-03-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joseph M Miller
Joseph M Miller Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph M Miller owns 2 companies in total, including Avalo Therapeutics Inc (AVTX) , and Aurinia Pharmaceuticals Inc (AUPH) .
Click here to see the complete history of Joseph M Miller’s form 4 insider trades.
Insider Ownership Summary of Joseph M Miller
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2021-12-31 | director |
| AUPH | Aurinia Pharmaceuticals Inc | 2024-03-06 | Chief Financial Officer |
Joseph M Miller Latest Holdings Summary
Joseph M Miller currently owns a total of 2 stocks. Among these stocks, Joseph M Miller owns 495,928 shares of Aurinia Pharmaceuticals Inc (AUPH) as of March 6, 2024, with a value of $4 Million and a weighting of 100%. Joseph M Miller also owns 17 shares of Avalo Therapeutics Inc (AVTX) as of December 10, 2019, with a value of $162 and a weighting of 0%.
Latest Holdings of Joseph M Miller
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc | 2024-03-06 | 495,928 | 8.85 | 4,388,963 |
| AVTX | Avalo Therapeutics Inc | 2019-12-10 | 17 | 9.55 | 162 |
Holding Weightings of Joseph M Miller
Joseph M Miller Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph M Miller has made a total of 5 transactions in Aurinia Pharmaceuticals Inc (AUPH) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Aurinia Pharmaceuticals Inc is the sale of 34,811 shares on March 6, 2024, which brought Joseph M Miller around $194,942.
According to the SEC Form 4 filings, Joseph M Miller has made a total of 1 transactions in Avalo Therapeutics Inc (AVTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Avalo Therapeutics Inc is the acquisition of 1 shares on December 10, 2019, which cost Joseph M Miller around $7,404.
Insider Trading History of Joseph M Miller
- 1
Joseph M Miller Trading Performance
GuruFocus tracks the stock performance after each of Joseph M Miller's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph M Miller is -8.66%. GuruFocus also compares Joseph M Miller's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph M Miller within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joseph M Miller's insider trading performs compared to the benchmark.
Performance of Joseph M Miller
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.11 | | | | | |
| Relative Return to S&P 500(%) | 13.7 | | | | | |
Joseph M Miller Ownership Network
Joseph M Miller Owned Company Details
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
Joseph M Miller is the director of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, Joseph M Miller made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 34,840 shares made by Caissa Capital Management Ltd. , a net sale of 3,683,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 4,000 shares made by Garry Arthur Neil .
In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 1,000 shares, with a net purchase of 1,000 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 1,164 shares were bought by its insiders, resulting in a net sale of 14,184 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
Joseph M Miller Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph M Miller. You might contact Joseph M Miller via mailing address: C/o Cerecor Inc., 400 East Pratt Street, Suite 606, Baltimore Md 21202.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
